ストックスクリーナーアプリを入手
28.68
3.47%
0.9631
前日終値:
$27.72
開ける：
$27.65
24時間の取引高:
1.80M
Relative Volume:
1.01
時価総額：
$4.55B
収益：
$264.79M
当期純損益:
$-14.36M
株価収益率:
-260.76
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
-2.48%
1か月 パフォーマンス:
-8.51%
6か月 パフォーマンス:
-22.66%
1年 パフォーマンス:
+3.65%
1日の値動き範囲:
$26.89
$28.91
1週間の範囲:
$26.89
$30.90
52週間の値動き範囲:
$25.28
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
28.67 | 4.40B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.73 | 116.86B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.31 | 80.72B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
810.45 | 49.26B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
372.69 | 49.00B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.50 | 36.96B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | 再開されました | H.C. Wainwright | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
Aug PostEarnings: Is TG Therapeutics Inc still a buy after recent gains2025 Buyback Activity & Safe Capital Investment Plans - baoquankhu1.vn
TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise - MSN
TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX - TechStock²
Market Leaders: Why TG Therapeutics Inc. stock is in analyst buy zone2025 Major Catalysts & Proven Capital Preservation Methods - Улправда
TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next - TechStock²
How TG Therapeutics Inc. stock performs in stagflationDividend Hike & Target Return Focused Picks - Улправда
Will TG Therapeutics Inc. (NKB2) stock outperform global peers2025 Earnings Surprises & Low Risk Investment Opportunities - Улправда
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Buy Ratings and 51.25% Upside Potential - DirectorsTalk Interviews
Is TG Therapeutics Inc a good long term investmentBear Market Strategies & Follow Top Performers in the Community - earlytimes.in
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN
Discipline and Rules-Based Execution in TGTX Response - Stock Traders Daily
TG Therapeutics: What Wall Street Isn't Telling You (NASDAQ:TGTX) - Seeking Alpha
Why TG Therapeutics Stock Was Soaring This Week - MSN
Could The Market Be Wrong About TG Therapeutics, Inc. (NASDAQ:TGTX) Given Its Attractive Financial Prospects? - simplywall.st
Investing in TG Therapeutics (NASDAQ:TGTX) three years ago would have delivered you a 160% gain - Yahoo Finance
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Osaic Holdings Inc. Sells 39,445 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics Earnings Notes - Trefis
Trading the Move, Not the Narrative: (TGTX) Edition - Stock Traders Daily
Is the options market predicting a spike in TG Therapeutics stock? - MSN
TG Therapeutics (MIL:1TGTX) EV-to-OCF : -66.83 (As of Dec. 22, 2025) - GuruFocus
TG Therapeutics (STU:NKB2) EV-to-FCF : -66.70 (As of Dec. 21, 2025) - GuruFocus
TG Therapeutics (STU:NKB2) EV-to-OCF : -66.83 (As of Dec. 21, 2025) - GuruFocus
Will TG Therapeutics Inc. stock remain a Wall Street favorite2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда
Can TG Therapeutics Inc. stock surprise with earnings upsideQuarterly Earnings Report & Technical Pattern Based Signals - Улправда
Can TG Therapeutics Inc. stock sustain institutional interest2025 Market Overview & Short-Term Trading Alerts - DonanımHaber
Is the Options Market Predicting a Spike in TG Therapeutics Stock? - Zacks Investment Research
How buybacks impact TG Therapeutics Inc. stock valueTrade Risk Report & Free Risk Controlled Daily Trade Plans - Улправда
Can TG Therapeutics Inc. stock resist sector downturns2025 Earnings Surprises & Daily Profit Maximizing Tips - Улправда
Is TG Therapeutics Inc. (NKB2) stock expanding market penetration2025 Trade Ideas & AI Forecasted Entry and Exit Points - ulpravda.ru
Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Earnings Recap: Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Snapshot & Risk Controlled Stock Alerts - Улправда
Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда
Why TG Therapeutics Inc. stock remains on watchlistsJuly 2025 Highlights & Community Driven Trade Alerts - Улправда
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - sharewise.com
Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
(TGTX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Norges Bank Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Bought by Diadema Partners LP - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Jump Financial LLC - MarketBeat
Is TG Therapeutics (TGTX) Quietly Reframing Its Investment Story Around Neurology Depth Over Breadth? - Sahm
1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛
New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. $TGTX Shares Bought by Russell Investments Group Ltd. - MarketBeat
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
1.25%
0.93%
大文字化:
|
ボリューム (24 時間):